Dr Reddy’s will conduct trials and supply doses of Russian vaccine

Indian pharma company Dr Reddy’s Laboratories Ltd collaborated with the Russian Direct Investment Fund (RDIF) for clinical trials of the Russian Sputnik V vaccine. After the completion and approvals of Phase 3 human trials by Indian regulators, Dr Reddy’s will distribute up to 100 million doses of the vaccine in India. It is expected that delivery of the vaccine will happen by November 2020.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here